REQUEST A DEMO
Total
USD $0.00
Search more companies

Menta Pharma Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Menta Pharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: August 01, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Menta Pharma İlaç. San. ve Tic. Ltd. Şti is a Turkish pharmaceutical company. The company focuses on the discovery and development of new products with modern technology and FDA standards. Menta Pharma is committed to providing high-quality and effective products to the healthcare industry and makes significant R&D investments. The company operates in the health sector and offers internship opportunities to students.

Headquarters
No:35 Orta Mahallesi Universite Caddesi Tuzla
Istanbul; Marmara; Postal Code: 34956

Contact Details: Purchase the Menta Pharma Ilac A.S. report to view the information.

Website: http://www.mentapharma.com.tr

Basic Information
Total Employees:
Purchase the Menta Pharma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Menta Pharma Ilac A.S. report to view the information.
Incorporation Date:
June 29, 2015
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Menta Pharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-16.8%
Total operating revenue
-16.8%
Operating profit (EBIT)
-80.91%
Net Profit (Loss) for the Period
N/A
Total assets
27.08%
Total equity
196.09%
Operating Profit Margin (ROS)
-6.65%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-316.75%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?